News & Updates

Synbiotic supplementation of high-fibre diet promising for weight loss

07 Nov 2023 by

An open-label, randomized, parallel-design clinical trial demonstrates weight loss as well as decreases in fasting glucose, insulin and insulin resistance in overweight and obese Hong Kong Chinese individuals after high-fibre dietary intervention supplemented with synbiotics.

Synbiotic supplementation of high-fibre diet promising for weight loss

07 Nov 2023

Selpercatinib superior to standard MKIs for rare thyroid cancer

06 Nov 2023 by

Selpercatinib, a highly selective and potent RET inhibitor, trumped two multikinase inhibitors (MKIs) – cabozantinib and vandetanib – for the treatment of advanced, kinase inhibitor-naïve, RET-mutant medullary thyroid cancer (MTC) in the first-line (1L) setting, according to the interim analysis results of the phase III LIBRETTO-531 trial.

Selpercatinib superior to standard MKIs for rare thyroid cancer

06 Nov 2023

Effective management of type 2 diabetes mellitus with a combination of metformin and empagliflozin in a patient with metabolic syndrome

01 Nov 2023

Metabolic Syndrome (MS) is linked to insulin resistance and a combination of five medical conditions that increase the risk of developing atherosclerotic cardiovascular disease (ASCVD). Obesity is independently associated with an increased incidence of diabetes mellitus, hypertension, hyperlipidemia, cardiovascular disease (CVD), and certain cancers. Early CVD protection is crucial in MS patients with Type 2 diabetes (T2DM). The use of empagliflozin/metformin for managing T2DM in MS improved fasting blood glucose levels and HbA1c, demonstrating the effectiveness of this combination in both ASCVD and CVD risk factors patients.

Sponsored as an educational program by Boehringer Ingelheim Singapore Pte. Ltd.

Effective management of type 2 diabetes mellitus with a combination of metformin and empagliflozin in a patient with metabolic syndrome

01 Nov 2023

Diet-based weight loss improves biomarkers of endothelial function

31 Oct 2023 by

Weight loss induced by diet appears to improve biomarkers of endothelial function, according to a study. This intervention suggests a potential strategy to lower the risk of atherosclerosis.

Diet-based weight loss improves biomarkers of endothelial function

31 Oct 2023

Semaglutide benefits held up for 3 years

30 Oct 2023 by

Once weekly treatment with the glucagon-like peptide 1 receptor agonist (GLP-1 RA) semaglutide significantly reduced HbA_1c level and body weight in a large cohort of adults with type 2 diabetes (T2D) in a real-world study from Israel.

Semaglutide benefits held up for 3 years

30 Oct 2023

Remnant cholesterol ups GDM risk in pregnant women

29 Oct 2023

Increased levels of remnant cholesterol (RC) appear to elevate the risk of gestational diabetes mellitus (GDM), independent of traditional risk factors, suggests a study. Moreover, pregnant women with high prepregnancy body mass index (BMI), high triglyceride (TG), and high RC levels are at greater GDM risk.

Remnant cholesterol ups GDM risk in pregnant women

29 Oct 2023

Eating organic foods may protect against type 2 diabetes

28 Oct 2023

People who consume organically grown foods appear to have a reduced risk of type 2 diabetes mellitus, as shown in a study.

Eating organic foods may protect against type 2 diabetes

28 Oct 2023

Canagliflozin holds promise against MAFLD in T2D patients

27 Oct 2023 by

Patients with type 2 diabetes (T2D) who received canagliflozin benefit from improved liver biochemistry and metabolism, a recent study has shown. In addition, treatment with canagliflozin appears to confer positive effects on liver fibrosis.

Canagliflozin holds promise against MAFLD in T2D patients

27 Oct 2023

High red meat consumption increases risks of CVD and diabetes

27 Oct 2023 by

Higher consumption of both unprocessed and processed red meat is associated with higher risks of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM), according to a meta-analysis involving >4.4 million people by researchers from the University of Hong Kong (HKU).

High red meat consumption increases risks of CVD and diabetes

27 Oct 2023

Monoclonal antibody helps preserve muscle mass regardless of protein intake

25 Oct 2023 by

Treatment with bimagrumab appears to prevent muscle loss resulting from inadequate protein intake and increase muscle mass in the setting of enough protein intake, according to data from phase I and IIa studies.

Monoclonal antibody helps preserve muscle mass regardless of protein intake

25 Oct 2023

News & Updates

Filter by Specialty:

Specialty:

Synbiotic supplementation of high-fibre diet promising for weight loss

Synbiotic supplementation of high-fibre diet promising for weight loss

Selpercatinib superior to standard MKIs for rare thyroid cancer

Selpercatinib superior to standard MKIs for rare thyroid cancer

Effective management of type 2 diabetes mellitus with a combination of metformin and empagliflozin in a patient with metabolic syndrome

Effective management of type 2 diabetes mellitus with a combination of metformin and empagliflozin in a patient with metabolic syndrome

Diet-based weight loss improves biomarkers of endothelial function

Diet-based weight loss improves biomarkers of endothelial function

Semaglutide benefits held up for 3 years

Semaglutide benefits held up for 3 years

Remnant cholesterol ups GDM risk in pregnant women

Remnant cholesterol ups GDM risk in pregnant women

Eating organic foods may protect against type 2 diabetes

Eating organic foods may protect against type 2 diabetes

Canagliflozin holds promise against MAFLD in T2D patients

Canagliflozin holds promise against MAFLD in T2D patients

High red meat consumption increases risks of CVD and diabetes

High red meat consumption increases risks of CVD and diabetes

Monoclonal antibody helps preserve muscle mass regardless of protein intake

Monoclonal antibody helps preserve muscle mass regardless of protein intake